What is Jacomedic, and how/where does the company operate?
Jacomedic is a Norwegian private-owned company. For more than 30 years, we have been a supplier of medical devices to the Norwegian market. Our special field has always been airways products related to acute medicine, intensive care and anesthesia.
Could you explain how Jacomedic and its partners work together?
Jacomedic’s main focus is to supply high quality and innovative products. We use our ISO9001 and ISO14001 quality systems to qualify our partners. We keep close contact with our partners and like to invite partners to Norway, both for them to better understand our market, but also to build strong personal and social relationship to our partners.
Inovytec is one of Jacomedic’s partners and has been very active over the past 12 months; Inovytec’s Ventway Sparrow has proved invaluable to many healthcare providers that weren’t using it before. What makes it different than other ventilators?
The Ventway ‘Mobile’ ventilator was conceived by the inventors Nir Barkai and Mark Shahar after witnessing countless incidents in which EMS teams struggled with cumbersome mechanical ventilators. From the start, weight and durability were classified as two of the most important features of the new design, and, once combined with high-performance ventilation, it was clear the two had a game-changer on their hands.
The Ventway’s unique properties and design mean caregivers can manage both pediatric and adult patients with ease. Equipped with a user-friendly interface and a miniature turbine that draws ambient air from its surroundings, the Ventway is not reliant on an external oxygen supply. Additional features such as a 4.5 hours battery life (rechargeable and non-rechargeable), continuous alternate electrical adapters and power supply support, and Airworthiness Release Certification of up to 25,000 ft, allow for smooth transitions from the point of injury to the Emergency Department or Intensive Care Unit (ICU) and anywhere in between, providing an unparallel continuum of ventilation in one compact design.
Before the pandemic showed up for the first time, Inovyetc was well established in the Norwegian market through a running contract to supply every air ambulance with the Ventway Sparrow. That meant the Ventway was already well-known product in Norway when the pandemic broke loose. Beside the high performance and compact design, the Ventway is also really easy and intuitive to operate, which helped us produce quick and effective training online when the country locked down.
The Ventway has been through multiple rigorous tests, in particular, due to the climate and weather conditions it must be capable of functioning in.
Covid-19 has increased the pace of innovation in the healthcare technology sphere; what other products has Inovytec developed and brought to market in the past 12 months that are changing the efficacy of patient treatment protocols?
Until now, we have only been working with the Ventway in Norway, while closely following the SALI – an advanced critical aid system with constant connectivity to dispatcher, and can see a great potential also for this device.